The level of GFR and its magnitude of change over time are vital to the detection of kidney disease, understanding its severity and for making decisions about diagnosis, prognosis, and treatment, including drug dosing. GFR cannot be measured directly in humans; instead GFR is assessed either as measured GFR (mGFR) or estimated GFR (eGFR).
GFR is measured using plasma or urinary clearance of exogenous filtration markers. It is a cumbersome procedure and can only be performed in specialized centers in specific circumstances. GFR is therefore usually estimated from endogenous filtration markers.